Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a rapid and progressive loss of upper and lower motor neurons (MNs) (Ilieva et al. 2009 ). Patients suffer muscle weakness and paralysis due to the retraction of MN nerve terminals at striated muscles. Despite an impressive amount of knowledge on MNs in the CNS, there is a limited knowledge of the mechanisms that contribute to the loss of this distal synapse, the neuromuscular junction (NMJ). Yet, the destruction of the NMJ is a major determinant of disease progression and severity in ALS since NMJ degeneration still occurs even when MN degeneration is rescued from mutant superoxide dismutase 1 (SOD1)-mediated death (Gould et al. 2006) . Indeed, several in vivo studies reveal a complete dissociation between MN death and NMJ denervation (Gould et al. 2006; Dewil et al. 2007; Suzuki et al. 2007) , identifying the presynaptic nerve terminal of the MN and its environment as one potential site of distinctive mutation-mediated toxicity. Since the NMJ is a complex cellular structure composed of different compartments necessary for its proper function and repair, understanding how each component copes with ALS may reveal unexplored mechanisms contributing to ALS pathophysiology and perhaps pave the way to novel therapeutic approaches.
A landmark discovery, reported in 2003 using a mutant SOD1 rodent model, was that cell types other than MNs are contributors to ALS pathogenesis and progression (Clement et al. 2003) . For instance, non-neuronal cells that do not express mutant SOD1 delay degeneration and significantly extend survival of mutant-expressing MNs. However, mutant SOD1 protein expression in both MNs and glial cells is sufficient to induce MN nerve terminal degeneration, while expression in either MNs, astrocytes or muscles alone is not (for review see Ilieva et al. 2009 ). Although the case for glia contributing to ALS-related MN degeneration is clear in the CNS, it has been less well considered in the periphery. Interestingly, a number of studies highlight potential glial cell involvement in the peripheral nervous system (PNS) (De Winter et al. 2006; Keller et al. 2009; Carrasco et al. 2010 Carrasco et al. , 2016a Arbour et al. 2015) , raising the possibility that the signalling between MN nerve terminals and glial cells might be a critical element in the maintenance of NMJ integrity.
Perisynaptic Schwann cells (PSCs; also called terminal Schwann cells) are specialized glial cells at the NMJ (see Fig. 1 ) which play crucial roles in all major aspects of NMJ functions, including synapse formation, maintenance, repair and regulation of synaptic efficacy. However, little is known regarding the role of these cells in driving ALS-related pathological changes. Owing to PSC roles at the NMJ, it is imperative to analyse this synapse with a novel perspective, considering not only the MN but also its associated glia. In this review, we will discuss the intercellular interactions between the presynaptic motor nerve terminal and PSCs and examine outstanding issues in ALS. Specifically, we will focus on the impact of these neuron-glia interactions at the NMJ during synaptic changes and denervation, as well as molecular and age-dependent perturbations that occur in ALS, highlighting the potential heterogeneous contribution of this distinct glial cell population to this disease.
ALS-related electrophysiological changes in MNs and NMJs
It has been suggested that MN excitability and activation might influence the progression rates of motor dysfunction, MN death and NMJ denervation (Gordon et al. 2010; Saxena et al. 2013) . Therefore, intrinsic spinal MN excitability appears to be a key issue in ALS and relevant to disease. However, MN excitability dysfunction that might influence synaptic output at the NMJ remains ill-defined.
In the first part of this section, we will review the current status of MN excitability and NMJ synaptic impairments in ALS. Unfortunately, in most publications, MN cell body excitability and nerve terminal properties have been 
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A, ALS is characterized by MN loss, axonal degeneration and NMJ destruction. The MN cell body is located in the ventral horn of the spinal cord while the axon projects outside of the CNS to directly innervate multiple muscle fibres (motor unit). The MN cell body and its local environment (dotted area highlights the region enlarged in B) are important sites of mutation-mediated toxicity. Indeed, the contribution of glial cells (B, microglia in green, astrocyte in red and oligodendrocyte in blue) in disease development and progression is well established in the CNS. However, the contribution of glial cells at the NMJ, the output of the MNs in the PNS, remains ill-defined. C, the NMJ is composed of three synaptic elements: the presynaptic nerve terminal (green), the postsynaptic motor endplate enriched in nicotinic receptors (red stripes on the darker pink muscle fibre) and the perisynaptic Schwann cells (PSCs; blue). Note that these three synaptic elements are precisely aligned with each other. Unlike motor axons that are wrapped with myelinating Schwann cells, the nerve terminal is only covered by non-myelinating PSCs that do not invade the synaptic cleft. A close view of the dotted area in C represents the sagittal plane of the NMJ shown in D. The different components and the potential interactions between them are described in Fig. 2. J Physiol 595.3 investigated as two separate entities, making direct causal links difficult. Since the majority of published results on functional NMJ synaptic properties have been performed in SOD1 mouse models, data on other ALS-causative genes will be included wherever possible. In the second part, NMJ synaptic impairments will be revisited by considering not only the neuronal component but also adding PSCs into this tripartite synapse. Investigating glial contributions to the modulation of synaptic activity at the NMJ and how disease can affect these neuron-glia interactions in the PNS will provide a better-integrated view of NMJ alterations in ALS.
Altered MN excitability and NMJ synaptic impairments in ALS. Early alterations in spinal MN electrical properties have been reported in ALS. Indeed, enhanced intrinsic excitability was observed in spinal MNs from mutant SOD1
G93A embryos recorded in culture and in organotypic slices (Pieri et al. 2003; Kuo et al. 2004) . At a time when synaptic competition was still present at the NMJ, excitability of lumbar MNs of 7-day-old SOD1 G93A animals appears unchanged compared to controls (Quinlan et al. 2011 ). This was due to an increase in the input conductance of MNs (Bories et al. 2007 ) that compensated for increased Na + voltage-dependent currents (Quinlan et al. 2011) . Importantly, another study performed in the same temporal window reported that Slow-type MNs are hyperexcitable while Fast-type MNs are not (Leroy et al. 2014) . It is well considered that the large MNs which innervate fast-contracting muscles fibres are more vulnerable in ALS. In contrast, small MNs innervating slow-contracting fibres are more resistant to the disease. Therefore, MN subtypes may account for the apparent discrepancies observed in these early developmental processes and the early phase of the disease.
A recent study by Delestree et al. (2014) investigated the intrinsic electrical properties of adult mouse MNs both in vitro and in vivo. They showed that while NMJ denervation was ongoing in adult SOD1 G93A mice, the excitability of MNs in the lumbar or sacrocaudal region is unchanged compared to wild-type (wt) animals. However, they also reported that a large subpopulation of MNs become hypoexcitable suggesting that MN hyperexcitability may be an early and transient event in SOD1 G93A mice and that this hypoexcitability could be an marker of early disease (Delestree et al. 2014) . Moreover, this further suggests that at the time NMJs face important morphological modifications (synaptic competition and denervation), electrical properties of spinal MNs undergo functional changes in the mutant SOD1 mouse model of ALS. Interestingly, a temporal analysis of human induced pluripotent stem cell (iPSC)-derived MNs harbouring mutations in different genes associated with ALS also display initial hyperexcitability (Dewil et al. 2007; Wainger et al. 2014) . However, even in this human cell-based model, controversial results have been reported (Sareen et al. 2013) , emphasizing the crucial need to understand the intrinsic electrical properties of MNs and the ability of MNs to generate an appropriate synaptic output at the NMJ.
Synaptic transmission at the NMJ is altered early in non-SOD1 models of ALS. Indeed, synaptic transmission at the NMJ of fast-twitch-like muscles is reduced in larval zebrafish expressing human FUS and TDP-43 disease-associated mutations (Armstrong & Drapeau, 2013a,b) and in FUS-expressing Drosophila larvae (Shahidullah et al. 2013; Machamer et al. 2014) . However, no such comparison has yet been performed in mutant SOD1 animals (during development of fast-twitch muscles). However, at the pre-symptomatic phase of the disease in mutant SOD1 mice (G93A and G37R mutations), synaptic transmission is enhanced at mature and stable NMJs (Rocha et al. 2013; Arbour et al. 2015) . This was reported in two different nerve-muscle preparations (diaphragm and soleus) characterized by the same motor unit (MU) composition (slow (S) -and fast-fatigue resistant (FR)). Interestingly, this abnormal nerve-evoked synaptic property was only observed at NMJs with slow properties (the more disease-resistant ones) (Arbour et al. 2015) , supporting the idea that their higher resilience to disease may be related to higher synaptic strength (Saxena et al. 2013; Leroy et al. 2014) . In symptomatic SOD1
G93A mice, where NMJ denervation is already ongoing, data reveal at least two distinct groups of NMJs: one having the same synaptic properties as their wild-type littermates and the other group exhibiting reduced synaptic strength (Rocha et al. 2013) . Again, it is noteworthy to mention that MU subtypes may explain this divergence in NMJ synaptic properties over the course of the disease. Thus, given the numerous fundamental differences in the properties of MNs and NMJs, extrapolating NMJ synaptic impairment based on MN excitability or vice versa is risky.
Dissecting disease-relevant causality relationships between MN and NMJ synaptic impairments has remained challenging, mainly due to the technical difficulties inherent to the murine model. Interestingly, to the best of our knowledge, only two studies have reported recordings of both MN and NMJ synaptic activity in other model organisms in the early phase of the disease process. For instance, in the mutant FUS zebrafish larvae model, MNs were found to be more excitable and synaptic transmission at the NMJ of fast-twitch muscles was reduced (Armstrong & Drapeau, 2013b) while in mutant FUS Drosophila larvae, a normal electrical excitability of the MN cell body and axon was reported despite a severe decrease in neurotransmitter release at the NMJ (Shahidullah et al. 2013) . According to these results, regardless of the status of MN excitability, synaptic impairment at the NMJ during development seems to be a common feature in these models of ALS.
Although any generalization should be considered with caution, it appears that MN excitability and NMJ synaptic alterations are dependent on disease progression, MU subtypes and mutation, all of which add additional levels of complexity for the treatment of this disease. Hence, a thorough longitudinal analysis of MN excitability and NMJ synaptic changes is required to more accurately define how MN properties ultimately influence NMJ functions and establish the selective synaptic properties relevant to MN vulnerability and resistance in ALS. This could provide insight into how the relationship of MN excitability and NMJ synaptic dysfunctions relates to the vulnerability of the lower motor circuit in ALS. However, it is very important to highlight that, besides MN and NMJ properties, strong evidence indicates that alterations are also present at several other levels of the motor circuit in ALS (reviewed in de Carvalho et al. 2014) .
Cross-talk of MN nerve terminals and PSCs for coordinated synaptic efficacy at the NMJ. Because of their role at the NMJ, it is necessary to incorporate PSCs as active partners to obtain a better integrated perspective of NMJ functions in ALS. By considering the bidirectional relationship between MN nerve terminals and associated glia in the regulation of synaptic output, we will focus on how synaptic activity regulates PSC activity and properties and how, in return, PSCs influence NMJ synaptic properties.
First, PSCs are normally tuned with their associated motor nerve terminal. For example, neurotransmitter release by the motor nerve terminal mobilizes PSC G-protein-coupled receptors (GPCRs; mainly muscarinic and purinergic receptors) that control an inositol 1,4,5-trisphosphate (IP 3 )-mediated mechanism and Ca 2+ release from internal endoplasmic reticulum (ER) stores (Castonguay & Robitaille, 2001; Rochon et al. 2001; Darabid et al. 2013) . This PSC Ca 2+ response is not only a good reporter of their excitability but also a reliable indicator of their decoding ability. That is to say that it reflects the ability of PSCs to distinguish differences of synaptic strength between two competing nerve terminals at the same NMJ (Darabid et al. 2013) , or two different types of NMJs (fast and slow) (Rousse et al. 2010) , or even detect different patterns of neuronal activity (Todd et al. 2010) . Furthermore, similar to neurons, changes in synaptic activity trigger dynamic and plastic changes in PSC properties, especially muscarinic sensitivity (Belair et al. 2010) , suggesting that PSC activity and properties are adaptable to a given synaptic environment.
Second, PSCs can influence synaptic activity and NMJ stability. For instance, selective in vivo ablation of PSCs at adult vertebrate NMJs causes a decrease in neurotransmitter release as well as motor nerve terminal retraction (Reddy et al. 2003) , highlighting the importance of PSCs in NMJ synaptic function and innervation. In addition, PSCs integrate the activity of the synapse and balance the strength of the connection under normal physiological conditions. More specifically, by releasing different gliotransmitters (e.g. ATP), PSCs will elicit different forms of short-term synaptic plasticity (potentiation or depression) owing to the different kinetics of Ca 2+ responses (i.e. timing, duration, pattern) that they generate (Todd et al. 2010) . Interestingly, PSC Ca 2+ responses are both sufficient and necessary for the induction of these synaptic plasticity events (Todd et al. 2010) . Furthermore, the specific and direct activation of PSC IP 3 receptors leading to Ca 2+ release or the modulation of PSC G-protein activity can either potentiate or decrease synaptic efficacy, respectively (Robitaille, 1998; Castonguay & Robitaille, 2001) . As a whole, PSCs participate in the fine-tuning of the net output at the NMJ. However, whether PSC functions are altered in the pathological context of ALS remains an open question.
An interesting but unexplored avenue in ALS research is the relative influence of the motor nerve terminal on PSC activity and properties, and vice versa. A recent study showed that the ability of PSCs to decode synaptic transmission was greatly altered in a mutant SOD1 mouse model, such that PSC Ca 2+ responses elicited by motor nerve stimulation were significantly enhanced (Arbour et al. 2015) . Moreover, PSC Ca 2+ responses did not correlate with the specific strength of the motor nerve terminal at the soleus muscle of SOD1 G37R mice. This mismatch between synaptic and PSC properties of NMJs in this ALS model suggests that PSCs lose their ability to adapt to a given synaptic environment and instead function according to their own intrinsic glial properties. Indeed, while the altered synaptic strength was stable throughout the pre-symptomatic phase of the disease in SOD1 G37R mice, the sensitivity of PSC receptors gradually increased toward disease onset and became dependent on MU vulnerability (Arbour et al. 2015) . This raises the question as to whether intrinsic glial cell properties alter synaptic activity and plasticity at the NMJ throughout the different disease stages. Furthermore, an alteration of A 1 /A 2A receptors, which are the target of PSC gliotransmitters, has been reported in mutant SOD1 mice (Nascimento et al. 2014; Nascimento et al. 2015) . The same group proposes that the level of extracellular adenosine is increased at the synaptic cleft during the symptomatic phase of ALS (Nascimento et al. 2015) , which may suggest a possible altered release of this PSC gliotransmitter in ALS.
Changes in neuron-glia interactions at the NMJ in ALS.
Surprisingly, there is limited information on the ALS disease process at the NMJ. Thus, we will explore different mechanisms known to influence MNs and discuss their possible relevance in the context of the NMJs. More J Physiol 595.3 specifically, concepts that are thought to contribute to MN vulnerability in ALS will be exported to PSCs, such as Ca 2+ mishandling, ER and oxidative stress, which can all affect synaptic transmission. These mechanisms could represent potential targets for prospective therapeutic treatments.
Since mutant SOD1 expression induces ER stress affecting MN cell bodies (Saxena et al. 2009 ), a dysfunction affecting neuron-glia interactions at the NMJ may be related to ER stress regulation and mitochondrial function. Indeed, SOD1 mutations are known to interfere with these two highly interconnected organelles of MNs in ALS (reviewed in Ilieva et al. 2009 ). Interestingly, the membranous contact between these two organelles seems to be the host of protein interactions related to intracellular Ca 2+ handling through IP 3 activation (Manfredi & Kawamata, 2016) . Importantly, IP 3 activation regulates PSC Ca 2+ elevations and potentiates transmitter release (Castonguay & Robitaille, 2001) . Given that PSC Ca 2+ responses are altered in ALS (Arbour et al. 2015) , SOD1 mutations may affect PSC IP 3 regulation via ER-mitochondria misregulation resulting in profound effects on PSC Ca 2+ signalling and synaptic transmission at the NMJ.
Mutant SOD1 expression also increases Ca 2+ accumulation in the motor nerve terminal (Siklos et al. 1996) and yields abnormal ER Ca 2+ release in cultured SOD1 G93A astrocytes (Kawamata et al. 2014) . Given the importance of Ca 2+ -dependent signalling by PSCs in the decoding and modulation of synaptic activity and the altered PSC Ca 2+ properties in ALS models (Arbour et al. 2015) , a dysfunction in PSC Ca 2+ -dependent functions could be detrimental for NMJ synaptic function. Thus, one might argue that NMJ synaptic function in ALS could be restored by targeting PSC Ca 2+ signalling. However, no direct evidence is yet available on PSC Ca 2+ regulation of synaptic functions in ALS. Another possible mechanism is that mutant SOD1 protein interacts with PSC muscarinic receptors (mAChRs) and alters their signal transduction yielding increased intracellular Ca 2+ concentrations (Damiano et al. 2013) . Based on PSC mAChR over-activation during synaptic communication, an early and persistent abnormal PSC decoding ability was observed in mutant SOD1 mice (Arbour et al. 2015) . This would be predicted to contribute to the maintenance of inefficient PSC responses to changes in synaptic properties during the progression of ALS-related NMJ denervation.
PSC over-activation in ALS could also lead to substantial cellular damage via disruption of fundamental cellular pathways. Indeed, glial over-activation leads to increased intracellular Ca 2+ levels in ALS models (Kawamata et al. 2014; Arbour et al. 2015) . Moreover, since Ca 2+ is an important second messenger implicated in multiple cellular functions, other Ca 2+ -dependent signalling pathways could also be altered and possibly be deleterious for normal glial cell function. Glial over-activation could also enhance free radical production and consequent mitochondrial overload, redox disturbances and membrane damage. This cascade of events may ultimately lead to ER and oxidative stress. Interestingly, this greatly correlates with the cellular perturbations observed in MNs expressing SOD1 mutations (for review see Ilieva et al. 2009 ). Therefore, major pathway dysfunctions affecting MNs can also be critical for its associated glia.
The role of PSCs in pathological changes at the NMJ It remains unclear how MN degeneration and NMJ denervation impact on each other. In particular, there are two main opposing hypotheses proposed to explain the origin of NMJ denervation. The dying-forward hypothesis proposes that the earliest degenerative process starts from the upper MNs and descends to the NMJ (Menon et al. 2014; Thomsen et al. 2014) . In contrast, the dying-back hypothesis posits that the degenerative process starts at the level of the NMJs (Fischer et al. 2004; Pun et al. 2006) . Regardless of the starting point or if MNs undergo significant stress originating from both the CNS and the PNS, the inevitable loss of neuromuscular synapses is a key event in ALS. Thus, understanding the dysfunctions that are involved in NMJ denervation is critical for improving our understanding of ALS. In this section, we will focus on the characterization of the denervation process at the NMJ, the differential susceptibility of MUs to denervation and re-innervation, and the possible implications of PSCs in these processes.
Denervation and differential susceptibility to denervation in ALS. Although a fundamental event in ALS, the temporal sequence of NMJ denervation remains ill defined. For instance, the morphological sequences by which NMJs are selectively dismantled in ALS do not fit with Wallerian degeneration. Wallerian degeneration is characterized by a series of specific cellular and molecular axonal mechanisms that define the disconnection between the motor nerve terminal and muscle fibres following axonal injury and in normal aging (Gillingwater & Ribchester, 2003) . In contrast, NMJ denervation in the context of ALS is characterized by a gradual retraction of the motor nerve terminal without any gross fragmentation or major disintegration of the myelin sheath (Murray et al. 2008) . In many aspects, this process is reminiscent of the cellular mechanisms that occur during pruning of excess axonal inputs at NMJs during synaptic competition (Gillingwater & Ribchester, 2003; Schaefer et al. 2005; Darabid et al. 2014) . This is corroborated by the inability of the spontaneous mutation Wld s , which confers delayed Wallerian degeneration, to rescue mutant SOD1 mice (G37R and G85R) (Vande Velde et al. 2004) , although a contradictory report using SOD1 G93A mice claimed a very modest extension in survival and delayed NMJ denervation exclusively in females (Fischer et al. 2005) .
There is a positive correlation between NMJ denervation and the degree of MN vulnerability. Indeed, it is reported that NMJs from fast-fatigable (FF) MUs are affected selectively, synchronously and early on and to a lesser extent than fast-resistant NMJs (Atkin et al. 2005; Pun et al. 2006; Hegedus et al. 2007 Hegedus et al. , 2008 . Furthermore, NMJs with S properties are partially resistant to the disease and their resistance permits them to compensate for the denervation of NMJs from FF MUs (Frey et al. 2000; Schaefer et al. 2005; Pun et al. 2006) . This compensatory mechanism is mainly due to the sprouting of the remaining motor nerve terminals that attempt to re-innervate previously denervated NMJs. This causes an enlargement of the MUs, which eventually fail to counterbalance for the degeneration occurring in the disease (Tam et al. 2001; Schaefer et al. 2005; Pun et al. 2006) . One could also argue that increased MU size may further exacerbate the oxidative stress and/or metabolic demand experienced by the compensating MNs, leading to its potential degeneration and elimination, effectively establishing a vicious cycle. However, the underlying mechanisms that account for the differential susceptibility to denervation and re-innervation among MUs remain ill defined.
NMJ susceptibility to denervation and the lack of anatomical plasticity (or sprouting capacity) may depend on the specific properties of NMJ components, i.e. motor nerve terminal, muscle fibre and PSC. A contributing factor may be the existence of profound differences among MNs themselves. Lichtman's group reported that degenerative (denervation) versus regenerative (re-innervation) changes are largely confined to distinct populations of MNs within the same motor pool in SOD1 G93A mice (Schaefer et al. 2005) . In other words, amongst the fast MUs, some motor nerve terminals are in the process of degenerating or compensating, but not both. Thus, although susceptibility in ALS could be attributed to intrinsic MN factors, differential regulation by the local environment at the NMJ also appears to be important (Frey et al. 2000; Pun et al. 2002; Gould et al. 2006) . Adding further support for potential peripheral disease mechanisms, it has been proposed that, following injury in healthy animals, the re-innervation process is more effective at FF NMJs than S NMJs. Specifically, the recovery after nerve injury is faster and the effects of structural degeneration are less pronounced (Nishizawa et al. 2006) . Thus, even though FF NMJs are more amenable to re-innervation in non-pathological conditions, they succumb first to ALS-related degeneration, suggesting that additional toxic mechanisms must contribute to FF NMJ loss in ALS.
With regards to the muscle, there is no simple correlation between the level of transgenic SOD1 expression or aggregation and the differential vulnerability of muscle fibre types in SOD1 G93A mice (Atkin et al. 2005) . Furthermore, the reduction of mutant SOD1 synthesis and accumulation via viral delivery of hRNA or by selective mutant gene excision within muscles did not affect onset, progression or survival of SOD1 mice (Miller et al. 2006) . Moreover, it appears that motor nerve terminal degeneration is independent of muscle-restricted expression of the mutant protein, but seems rather dependent on the pairing of mutant-expressing MN axons/nerve terminals and Schwann cells (Carrasco et al. 2010) . Thus, similar to the apparent limited contribution of muscles to ALS pathogenesis, they may also not be implicated in specific NMJ resistance and plasticity. In contrast, various PSC-related mechanisms have been described as potential contributors to NMJ susceptibility. For instance, semaphorin 3A (Sema3A) is selectively expressed by PSCs at FF NMJs in SOD1 G93A mice (De Winter et al. 2006) , suggesting that the chemorepellent release of Sema3A by PSCs may participate in the restricted anatomical plasticity of this particular subset of NMJs. Therefore, it is plausible (if not likely) that PSCs influence motor nerve terminal sprouting capacity during the course of ALS.
The close and dynamic relationship between PSCs and a motor nerve terminal are primarily governed by the innervation state of the NMJ (i.e. innervated versus denervated). Indeed, PSCs are exquisitely sensitive to the level of activity at the NMJ. When deprived of synaptic activity, PSCs will drastically change their gene expression profile by upregulating glial fibrillary acidic protein (GFAP), growth-associated protein-43 (GAP-43), low-affinity nerve growth factor (NGF) receptor p75, nestin, cell adhesion molecule CD44 and transcriptional factor zinc-finger proliferation 1 (Zipro1) (reviewed in Sugiura & Lin, 2011) . However, the implication of these genes in NMJ re-innervation remains unexplored. In addition, PSCs are an indispensable participant in the re-innervation process by inducing major plastic changes in their morphology. Results from multiple groups demonstrate that PSCs at denervated NMJs rapidly extend processes towards innervated NMJs (termed bridges). In turn, they initiate the formation of nerve terminal sprouts towards the denervated NMJ (referred to as sprouting) (Reynolds & Woolf, 1992; Son & Thompson, 1995a,b; O'Malley et al. 1999) . This indicates that PSCs might be crucial for NMJ plasticity and repair. Interestingly, there is a link between synaptic activity and PSC-mediated repair of the NMJ. In fact, the number of bridges and sprouting is regulated by synaptic activity (Love et al. 2003; Tam & Gordon, 2003) . This suggests that an adequate level of synaptic signalling from all NMJ components to PSCs is necessary for PSCs to reach innervated NMJs and guide the sprouting nerve terminal back towards the denervated NMJ (Tam & Gordon, 2003) . Thus, PSC anatomical plasticity at a denervated NMJ is a crucial adaptation and repair process, and there is a need to understand the factors that regulate this compensatory mechanism in ALS.
PSC process extension and sprouting have been observed in ALS patients and mouse models of ALS (Frey et al. 2000; Gordon et al. 2004; Gould et al. 2006; Arbour et al. 2015; Tallon et al. 2015) . However, the extent of sprouting reported is very limited and most of the observed sprouts were not directed toward areas of denervated NMJs (Tallon et al. 2015) . Moreover, there is evidence that this re-innervation mechanism is deficient following denervation in ALS (Gordon et al. 2004; Arbour et al. 2015) . The progressive failure of this adaptive sprouting in ALS may be indicative of a change in PSC decoding ability and/or properties since it is the first step that permits them to evaluate the innervation state of the NMJ. For example, when an NMJ is denervated, neurotransmitter release is decreased and there is a consequent failure of endogenous acetylcholine to activate mAChRs located on PSCs (see next section for more details) and GFAP is upregulated (Georgiou et al. 1994 (Georgiou et al. , 1999 . This suggests that there is a 'motor nerve terminal to PSC' signal requiring presynaptic neurotransmitter release, which regulates PSC gene expression and morphology. Thus, one could argue that the ability of PSCs to detect this presynaptic signal may be impaired and be a possible cause for inadequate NMJ repair as observed in ALS. However, a clear link between PSCs and NMJ repair still requires clarification in the pathological context of ALS.
One possible explanation for the altered ability of PSCs to decode and modulate NMJ synaptic activity could be the disruption in RNA regulation within PSCs. Indeed, a number of GPCR family members and cyclooxygenase-2 (COX-2) are among the transcripts bound by TDP-43 (Narayanan et al. 2013 ). These two elements are known to be present in PSCs and influence their ability to decode and modulate NMJ functions (Robitaille, 1998; Lindgren et al. 2013) . Since TDP-43-bound RNAs are implicated in synaptic function and are normally found at NMJs (Narayanan et al. 2013; Alami et al. 2014) , understanding TDP-43-related changes that occur in this mechanism may help identify links between the genetic causes of the disease and alterations of neuron-glia interactions at the NMJ in ALS.
Interactions between motor nerve terminals and
PSCs during re-innervation. Re-innervation of a denervated NMJ proceeds through several steps including phagocytosis of axonal debris, remodelling of the postsynaptic nicotinic receptors (nAChRs) and stabilization of the newly re-innervated NMJ. Several of these steps involve PSCs. For instance, PSCs acquire macrophagocytic-like behaviours that contribute to the removal of axonal debris after nerve injury or presynaptic poisoning with neurotoxin injection (Kang & Lichtman, 2013; Duregotti et al. 2015) . Importantly, facilitating the clearance of debris accelerates the rate of re-innervation at the NMJ (Kang & Lichtman, 2013) . Interestingly, signalling molecules released from the motor nerve terminal, which activate PSC macrophagocytic-like behaviours, seemed to be derived from mitochondria (Duregotti et al. 2015) , a preferential target of misfolded SOD1 toxicity (reviewed in Pickles & Vande Velde, 2012) . This suggests that debris clearance by PSCs may also be altered in ALS. Furthermore, during denervation, as indicated above, PSCs extend elaborate processes away from the NMJ, but they also retract others from endplate areas they previously occupied (Kang et al. 2014) . Hence, even if re-innervation very often occurs at the same previously occupied synaptic gutters, PSCs actively participate in synapse remodelling by influencing the removal or addition of postsynaptic receptor sites at re-innervated NMJs. Interestingly, the degree of the retraction depends on the length of the period of denervation (Kang et al. 2014) . In addition, the fact that regenerating axons preferentially follow PSC processes suggests that remodelling of the nerve terminal after re-innervation may occur, further implying that the newly re-innervated NMJ will be different from the initial one. Knowing that the re-innervation process eventually fails in ALS, it would be interesting to determine which factors influence debris clearance, duration of the re-innervation process and what retains PSC occupation of denervated synaptic sites. Importantly, even though re-innervation occurs in ALS, one could question if these newly re-formed NMJs are fully functional. Owing to PSCs' essential roles for NMJ establishment and maintenance (Reddy et al. 2003) , another interesting and as yet unexplored avenue in ALS would be to identify the signalling pathways that promote stabilization of newly re-formed synapses.
Adequate activation of PSCs is a key feature that influences the outcome of re-innervation. For instance, interruption of synaptic activity either by nerve crush/cut or synaptic blockade (tetrodotoxin or botulinum toxin) triggers an injury-like response in PSCs (i.e. GFAP upregulation, PSC processes extension, bridges and sprouting) (Georgiou et al. 1994; Son & Thompson, 1995a,b) that can be prevented by artificially maintaining the activation of PSC mAChRs (Georgiou et al. 1999) . This suggests that the ability of PSCs to switch from a maintenance mode to a repair mode is regulated by their capacity to detect synaptic transmission, specifically via the activation of their mAChRs. This phenotype is also induced by in vivo blockage of mAChRs at the NMJ (Wright et al. 2009 ). It is noteworthy that the contribution and the sensitivity of PSC mAChRs is greatly diminished in situations where major morphological and functional rearrangements of the NMJ are required. Consequently, a change in PSC muscarinic properties may contribute to the cascade of events ultimately causing impairment in NMJ re-innervation and repair. In other words, one could argue that an alteration of PSC mAChRs may affect their ability to decode a change in the state of innervation (innervated → denervated) preventing the switch to a repair mode (gene expression and morphological changes). Most interestingly, two muscarinic alterations in SOD1 G37R mice have been reported: (1) an early and persistent abnormal decoding ability of PSCs related to an enhanced muscarinic contribution during synaptic communication, and (2) a gradual increased sensitivity of PSC mAChRs towards disease onset that becomes dependent on MU vulnerability (Arbour et al. 2015) . Thus, as proposed earlier, PSC mAChRs may be the key for the proper detection of innervation state and repair of the NMJ in ALS (Ko & Robitaille, 2015) . Hence, based on the hyper-muscarinic activity of PSCs recently reported in ALS models (Arbour et al. 2015) , one could argue that dampening mAChR activity would restore the phenotype of PSCs, making them more amenable to NMJ repair and plasticity. However, the pathological relevance of the muscarinic hypothesis awaits further study.
Molecular and age-dependent interactions at the NMJ in ALS
In this section, we will briefly discuss which motor nerve terminal and PSC molecular or age-dependent interactions may be involved in the delicate balance to maintain NMJ structure and function (see Fig. 2 ). An extensive and detailed analysis was recently published by Moloney et al. (2014) . Molecular interactions. Synapse elimination, maturation, stability and repair of the NMJ are critical for its function. Neuregulin (NRG) is a family of alternatively spliced factors that are secreted or membrane-bound and signal through the ErbB family of receptor tyrosine kinases. The NRG-ErbB pathway mediates NMJ formation by increasing synthesis and clustering of postsynaptic nAChRs and associated proteins (reviewed in Darabid et al. 2014) . Importantly, this pathway has recently been found to be implicated in synapse elimination and plasticity at the NMJ (Lee et al. 2016) . Since, NRG and ErbB3 receptors have been localized at adult NMJs and ErbB3 specifically in PSCs (Trinidad et al. 2000; Gorlewicz et al. 2009 ), an interesting and protective role has been recently suggested for the NRG-ErbB pathway in ALS purported to act through the CD44 pathway (Moloney et al. 2014) .
However, a number of observations lead us to propose an alternate hypothesis: that NRG-ErbB signalling is counterproductive in the PNS. Indeed, exogenous application of NRG on innervated neonatal muscles induces motor nerve terminal retraction and migration of PSC somata away from endplates sites (Trachtenberg & Thompson, 1997) . Interestingly, these alterations in PSC position and morphology may be involved in nerve terminal retraction (Trachtenberg & Thompson, 1997; Carrasco et al. 2016a,b) . This suggests that the integrity of the NMJ is dependent on the stability of its PSCs (Reddy et al. 2003) and synaptic loss is thus probably mediated by changes in NRG-ErbB signalling in PSCs. Hence, we postulate that over-activation of this signalling may be implicated in the synaptic loss of NMJs in ALS. Moreover, expression of constitutively activated ErbB2 receptors in PSCs or an overexpression of NRG1 in motor axons induces PSC process extension, soma migration and proliferation, as well as sprouting of the motor nerve terminal and PSC phagocytic activity (Hayworth et al. 2006; Lee et al. 2016) , indicating that NRG-ErbB signalling is involved in PSC responses upon injury via autocrine/paracrine and/or axo-glial signalling. However, NRG1 expression is reported as significantly reduced in the spinal cords of two mutant SOD1 mouse models and ALS patients. On the other hand, viral-mediated delivery of NRG1 into the spinal cord restores the number of C-boutons and extends the survival of SOD1 G93A mice (Lasiene et al. 2016) . Hence, it would be important to determine the functionality of this pathway in ALS in the CNS as well as the PNS.
Another molecule that could have differential effects in the CNS and the PNS is transforming growth factor (TGF) β1. Astrocytic TGF-β1 probably controls neuroprotective immune responses by regulating microglial activation and T-cell number (Endo et al. 2015) . While astrocyte-derived TGF-β1 accelerates disease progression in ALS mice, which is ameliorated by a TGF-β1 signalling inhibitor (Endo et al. 2015) , Schwann cell-derived TGF-β1 (isolated from sciatic nerve) promotes synaptogenesis by significantly increasing the percentage of co-culture nerve-muscle contacts in vitro (Feng & Ko, 2008) . Moreover, Schwann cell-derived TGF-β1 upregulated agrin expression in spinal neuron somata in vitro (Feng & Ko, 2008) . Hence, TGF-β1 may play a critical role during the re-innervation process in ALS by promoting the re-establishment of nerve-muscle contacts. In addition, PSC-derived TGF-β1 could upregulate the release of agrin by the MN nerve terminal, increasing the stabilization of the newly re-formed NMJ.
Another interesting but still unexplored avenue in ALS is the implication of PSCs in the agrin/MuSK pathway for NMJ stability. Agrin and its receptor (muscle-specific kinase, MuSK) are implicated in NMJ assembly and maturation during development (for review see Darabid et al. 2014) . First, PSCs release agrin, as do neurons (Yang et al. 2001) and muscles (Burgess et al. 1999) . Since an increase in MuSK activity delays muscle denervation, improves muscle function and delays disease onset in SOD1 G93A mice (Perez-Garcia & Burden, 2012) , it is J Physiol 595.3 tempting to propose that the synthesis of agrin by PSCs may be deficient in ALS. Second, since agrin levels are controlled in part through degradation by matrix metalloproteinases (MMPs) (Darabid et al. 2014) , PSCs may regulate agrin levels by changing their secretion of MMPs. Interestingly, MMP-3 is expressed by PSCs at the NMJ and its expression is tightly regulated according to innervation state (VanSaun et al. 2007) . Moreover, persistence of agrin due to genetic deletion of MMP-3 leads to the preservation of endplates following nerve injury and degeneration (Chao et al. 2012 ) and modulation of neuronal MMP-9 levels significantly delays muscle denervation (Kaplan et al. 2014) . Collectively, these studies suggest that both motor nerve terminals and PSCs can modulate agrin levels via MMP secretion and, therefore, affect NMJ stability. In normal conditions (left panel), the presynaptic nerve terminal (green), the postsynaptic muscle fibre (pink) and the PSCs (blue) regulate synaptic functions in a coordinated fashion. Synaptic transmission is induced when an action potential reaches the presynaptic nerve terminal, activating voltage-dependent calcium channels. This activation will trigger a rapid calcium entry into the nerve terminal, and induce synaptic vesicle exocytosis and subsequent neurotransmitter release into the synaptic cleft. ACh will be co-released with ATP. ACh will bind to nAChRs on the muscle fibre and to mAChRs on PSCs. The binding of ACh to the nAChRs will depolarize the muscle fibre, which can result in the opening of voltage-dependent sodium channels and subsequent muscle contraction (myosin and actin movement). The binding of ACh to mAChRs will trigger an increase in intracellular Ca 2+ via the activation of the IP 3 receptors (IP 3 Rs) of the ER. ATP released during synaptic activity will be detected by PSCs via P2Y G-protein-coupled receptors. They, too, will trigger an increase of intra-PSC Ca 2+ concentration by releasing Ca 2+ from IP 3 -driven internal stores. In return, PSC detection of neurotransmission will regulate synaptic activity by acting on presynaptic adenosine receptors (A 1 /A 2A Rs). Interactions between MN nerve terminals and PSCs can also occur via different pathways that influence NMJ stability and repair. For example, PSCs express receptors such as ErbBs that, if activated, can influence NMJ structure. PSCs can also release TGF-β1 and agrin, and synthesize MMPs. TGF-β1 will promote NMJ formation and stability, while agrin, which can be cleaved by MMP, will act on the LRP4 (low density lipoprotein receptor-related protein 4)-MuSK complex to influence NMJ stability. Also, note the presence of mitochondria and wt SOD1 in all three synaptic elements. In ALS pathological conditions (right panel), these different PSC signalling pathways can be altered to promote NMJ denervation (D). Over-activation of PSC muscarinic pathway leads to greater intracellular Ca 2+ responses, alters gene expression and, hence, influences NMJ repair. Furthermore, the activation of the ErbB pathway can be implicated in alterations in PSC position and morphology as well as synaptic loss. Finally, the PSC agrin/MuSK pathway can be altered such that MMP release by PSCs can be upregulated and released agrin can be reduced, leading to NMJ instability. Boxes: hypothesis and proposed mechanisms. Dotted lines: pathways that are yet to be confirmed. Line thickness: relative increase or decrease of the pathway in comparison to the normal condition. LRP4, low density lipoprotein receptor-related protein 4; nAChR, nicotinic acetylcholine receptor; SOD1, superoxide dismutase 1.
terminals and PSCs during development and aging is essential to identify pathogenic mechanisms culminating in ALS phenotypes. It has been proposed that patterns of NMJ resistance and susceptibility are strikingly correlated in aging and ALS. Indeed, a comparison of NMJs in aged mice (22-28 months old) with those in SOD1 G93A mice reveals that most muscles are similarly affected or spared in aging and ALS and share molecular (i.e. TDP-43 mislocalization in MNs that supply susceptible muscles) as well as structural features (i.e. postsynaptic fragmentation, denervation, sprouting and poly-innervation) (Valdez et al. 2012) . Since some NMJs appear to share the same susceptibility in the face of adversity, it is tempting to extrapolate data obtained from aging studies to ALS. However, aging and ALS are two fundamentally different physiological conditions. Even if some NMJs from aged or ALS animals reach the same morphological endpoint, this does not necessarily imply that the underlying mechanisms to reach this point are similar. Comparative molecular and functional analyses must be evaluated critically and carefully as overlapping mechanisms may link these two processes, such that abnormalities that occur in normal aging could be exacerbated in ALS. For example, it has been proposed that impaired PSC sprouting in aged muscles following nerve injury may be responsible for poor re-innervation during aging (Kawabuchi et al. 2001) . Hence, the reciprocal interactions of motor nerve terminal and PSCs during aging might serve as another model to dissect out new contributing factors to NMJ repair failure in the context of ALS.
During aging and ALS, re-innervation occurs when an NMJ is denervated. Interestingly, re-innervation of the NMJ shares similar features with synapse formation, since the repair mechanisms recapitulate several steps observed during development (for reviews, see Darabid et al. 2014; Ko & Robitaille, 2015) . This suggests that mechanisms that influence NMJ assembly during development may also influence its disassembly and repair during adulthood. Along the same lines, Caroni's group has reported two distinct patterns of initial assembly of NMJs (fast and delayed synapsing). Interestingly, these two patterns of assembly correlate with two distinct patterns of disassembly, where NMJs from delayed synapsing muscles are more vulnerable to disassembly of AChR clusters after paralysis or denervation (Pun et al. 2002) . Surprisingly, there is no direct correlation between this specificity of assembly/disassembly and the different MU types, favouring again the notion that local factors at the NMJ could play valuable roles in NMJ stability. Importantly, a synaptic element that controls NMJ establishment, maintenance and repair is the PSC. Consistent with this idea, PSCs also have distinct process extension capacity at denervated muscles such that robust PSC process extension is detected at all NMJs in muscles with delayed synapsing, while it is weak in fast synapsing muscles (Pun et al. 2002) . Taken together, this suggests that distinct intrinsic factors implicated in NMJ synaptogenesis could provide the basis for understanding NMJ susceptibility/plasticity and/or PSC process extension capacity in the adult.
To date, little is known about what contributes to NMJ resistance in ALS. Considering that oculomotor and anal sphincter NMJs are mostly preserved in human and rodent models of aging and ALS (Valdez et al. 2012) , and while intrinsic differences in these MN pools have been reported by multiple groups (Nimchinsky et al. 2000; Comley et al. 2015) , another intriguing possibility is that PSCs at these specific NMJs have different properties. In fact, differential expression of distinct synaptically relevant proteins has been reported at oculomotor NMJs compared with limb muscle NMJs of ALS donors (i.e. S100β, GFAP, p75) (Liu et al. 2013) . All of these candidates are expressed by PSCs. Thus, whether PSCs have different decoding and repairing ability, and/or a distinctive molecular signature in resistant NMJs, such as those of the oculomotor pool or Onuf's nucleus, remains to be determined.
Conclusions
Owing to their numerous and essential roles at the NMJ, PSCs might hold the keys to understanding ALS etiology and pathomechanisms. PSCs play dynamic roles in multiple areas of NMJ function, such as modulating synaptic activity, promoting effective re-innervation processes and modifying molecular and age-dependent changes that could all lead to an exacerbation of the ALS phenotype. Overall, we propose that dysfunctions in neuron-glia interactions in the periphery may contribute to the pathological conditions of NMJs in ALS. Moreover, understanding PSC (dys)functions in ALS could provide the foundation for a new set of targets, perhaps opening new strategies to improve patients' quality of life.
Harnessing glial cells at NMJs may offer ways to maintain a higher level of muscle function for patients. Owing to the numerous functions of PSCs, these strategies may also prove useful for a broader group of motor neuron diseases.
